The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | Option exercise(M) | 5K | $5.06 | $25K |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | Sell(S) | 5K | $28.00 | $140K |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | Option exercise(M) | 5K | — | $0 |
| Jun 30, 2026 | Yao Zhengbin | Director | Grant(A) | 4K | — | $0 |
| Jun 30, 2026 | Yao Zhengbin | Director | Grant(A) | 16K | — | $0 |
| Jun 30, 2026 | Srivastava Sapna | Director | Grant(A) | 4K | — | $0 |
| Jun 30, 2026 | Srivastava Sapna | Director | Grant(A) | 16K | — | $0 |
| Jun 30, 2026 | Machado Patrick | Director | Grant(A) | 4K | — | $0 |
| Jun 30, 2026 | Machado Patrick | Director | Grant(A) | 16K | — | $0 |
| Jun 30, 2026 | Akkaraju Srinivas | Director | Grant(A) | 4K | — | $0 |
| Jun 30, 2026 | Akkaraju Srinivas | Director | Grant(A) | 16K | — | $0 |
| Jun 30, 2026 | Tetrault Lynn A. | Director | Grant(A) | 4K | — | $0 |
| Jun 30, 2026 | Tetrault Lynn A. | Director | Grant(A) | 16K | — | $0 |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | Option exercise(M) | 11K | — | $0 |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | Option exercise(M) | 16K | $5.06 | $79K |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | Option exercise(M) | 11K | $8.84 | $100K |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | Option exercise(M) | 16K | — | $0 |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | Other(J) | 1.2M | — | $0 |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | Other(J) | 680K | — | $0 |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | Other(J) | 1.2M | — | $0 |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Tananbaum James B. | Director, 10% Owner | Other(J) | 1.2M | — | $0 |
| Apr 1, 2026 | Tananbaum James B. | Director, 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Tananbaum James B. | Director, 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Tananbaum James B. | Director, 10% Owner | Other(J) | 680K | — | $0 |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | Other(J) | 1.1M | — | $0 |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | Other(J) | 680K | — | $0 |
| Jan 26, 2026 | Babler Martin | President, CEO and Chairman, Director | Grant(A) | 746K | — | $0 |
| Jan 26, 2026 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Grant(A) | 191K | — | $0 |
| Jan 26, 2026 | Schroer John R. | Chief Financial Officer | Grant(A) | 202K | — | $0 |
| Jan 26, 2026 | Goldstein David M | Chief Scientific Officer | Grant(A) | 217K | — | $0 |
| Jan 26, 2026 | Drappa Jorn | Chief Medical Officer | Grant(A) | 221K | — | $0 |
| Jan 26, 2026 | Bradley Mark Christopher | Chief Development Officer | Grant(A) | 190K | — | $0 |
| Jan 26, 2026 | Pangali Sanam | Chief Legal Officer | Grant(A) | 186K | — | $0 |
| Jan 9, 2026 | Akkaraju Srinivas | Director | Buy(P) | 588K | $17.00 | $10.0M |
| Jan 8, 2026 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 294K | $17.00 | $5.0M |
| Jan 8, 2026 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 118K | $17.00 | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P. | 10% Owner | Buy(P) | 118K | $17.00 | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P. | 10% Owner | Buy(P) | 294K | $17.00 | $5.0M |
| Jan 8, 2026 | Foresite Labs, LLC | 10% Owner | Buy(P) | 118K | $17.00 | $2.0M |
| Jan 8, 2026 | Foresite Labs, LLC | 10% Owner | Buy(P) | 294K | $17.00 | $5.0M |
| Dec 5, 2025 | Akkaraju Srinivas | Director | Buy(P) | 70K | $10.01 | $701K |
| Dec 5, 2025 | Akkaraju Srinivas | Director | Buy(P) | 51K | $10.73 | $551K |
| Dec 5, 2025 | Akkaraju Srinivas | Director | Buy(P) | 65K | $8.95 | $581K |
| Dec 4, 2025 | Akkaraju Srinivas | Director | Buy(P) | 66K | $8.18 | $540K |
| Dec 3, 2025 | Akkaraju Srinivas | Director | Buy(P) | 100K | $7.75 | $775K |
| Dec 2, 2025 | Akkaraju Srinivas | Director | Buy(P) | 96K | $7.55 | $725K |
| Dec 1, 2025 | Akkaraju Srinivas | Director | Buy(P) | 86K | $7.46 | $644K |
| Nov 28, 2025 | Akkaraju Srinivas | Director | Buy(P) | 39K | $7.64 | $296K |
| Nov 26, 2025 | Akkaraju Srinivas | Director | Buy(P) | 49K | $7.64 | $371K |
| Nov 21, 2025 | Foresite Labs Affiliates 2021, LLC | 10% Owner | Buy(P) | 72K | $7.38 | $533K |
| Nov 21, 2025 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 72K | $7.38 | $533K |
| Nov 21, 2025 | Foresite Labs Fund I, L.P. | 10% Owner | Buy(P) | 72K | $7.38 | $533K |
| Nov 20, 2025 | Akkaraju Srinivas | Director | Buy(P) | 126K | $7.20 | $905K |
| Nov 19, 2025 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 191K | $6.56 | $1.2M |
| Nov 19, 2025 | Foresite Capital Management VI LLC | 10% Owner | Buy(P) | 191K | $6.56 | $1.2M |
| Nov 19, 2025 | Foresite Labs Affiliates 2021, LLC | 10% Owner | Buy(P) | 191K | $6.56 | $1.2M |
| Nov 19, 2025 | Akkaraju Srinivas | Director | Buy(P) | 138K | $6.56 | $904K |
| Nov 18, 2025 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 117K | $6.19 | $727K |
| Nov 18, 2025 | Foresite Capital Management VI LLC | 10% Owner | Buy(P) | 117K | $6.19 | $727K |
| Nov 18, 2025 | Foresite Labs Affiliates 2021, LLC | 10% Owner | Buy(P) | 117K | $6.19 | $727K |
| Nov 18, 2025 | Akkaraju Srinivas | Director | Buy(P) | 103K | $6.05 | $621K |
| Nov 17, 2025 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 150K | $5.59 | $839K |
| Nov 17, 2025 | Tananbaum James B. | Director, 10% Owner | Buy(P) | 50K | $5.60 | $280K |
| Nov 17, 2025 | Foresite Capital Management VI LLC | 10% Owner | Buy(P) | 50K | $5.60 | $280K |
| Nov 17, 2025 | Foresite Capital Management VI LLC | 10% Owner | Buy(P) | 150K | $5.59 | $839K |
| Nov 17, 2025 | Foresite Labs Affiliates 2021, LLC | 10% Owner | Buy(P) | 50K | $5.60 | $280K |
| Nov 17, 2025 | Foresite Labs Affiliates 2021, LLC | 10% Owner | Buy(P) | 150K | $5.59 | $839K |
| Nov 17, 2025 | Akkaraju Srinivas | Director | Buy(P) | 914 | $5.51 | $5K |
| Nov 13, 2025 | Akkaraju Srinivas | Director | Buy(P) | 276K | $5.25 | $1.4M |
| Jul 30, 2025 | Akkaraju Srinivas | Director | Grant(A) | 50K | — | $0 |
| Jul 30, 2025 | Machado Patrick | Director | Grant(A) | 50K | — | $0 |
| Jul 30, 2025 | Srivastava Sapna | Director | Grant(A) | 50K | — | $0 |
| Jul 30, 2025 | Yao Zhengbin | Director | Grant(A) | 50K | — | $0 |
| Jul 30, 2025 | Tetrault Lynn A. | Director | Grant(A) | 50K | — | $0 |
| Jul 29, 2025 | Babler Martin | President, CEO and Chairman, Director | Grant(A) | 150K | — | $0 |
| Jul 29, 2025 | Babler Martin | President, CEO and Chairman, Director | Grant(A) | 662K | — | $0 |
| Jul 29, 2025 | Bradley Mark Christopher | Chief Development Officer | Grant(A) | 27K | — | $0 |
| Jul 29, 2025 | Bradley Mark Christopher | Chief Development Officer | Grant(A) | 107K | — | $0 |
| Jul 29, 2025 | Drappa Jorn | Chief Medical Officer | Grant(A) | 25K | — | $0 |
| Jul 29, 2025 | Drappa Jorn | Chief Medical Officer | Grant(A) | 102K | — | $0 |
| Jul 29, 2025 | Goldstein David M | Chief Scientific Officer | Grant(A) | 27K | — | $0 |
| Jul 29, 2025 | Goldstein David M | Chief Scientific Officer | Grant(A) | 108K | — | $0 |
| Jul 29, 2025 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Grant(A) | 28K | — | $0 |
| Jul 29, 2025 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Grant(A) | 112K | — | $0 |
| Jul 29, 2025 | Schroer John R. | Chief Financial Officer | Grant(A) | 28K | — | $0 |
| Jul 29, 2025 | Schroer John R. | Chief Financial Officer | Grant(A) | 112K | — | $0 |
| Jul 29, 2025 | Richardson Derrick | SVP, People and Culture | Grant(A) | 43K | — | $0 |
| Jul 29, 2025 | Richardson Derrick | SVP, People and Culture | Grant(A) | 64K | — | $0 |
| Jul 29, 2025 | Pangali Sanam | Chief Legal Officer | Grant(A) | 10K | — | $0 |
| Jul 29, 2025 | Pangali Sanam | Chief Legal Officer | Grant(A) | 40K | — | $0 |
| Jul 10, 2025 | Pangali Sanam | Chief Legal Officer | Grant(A) | 100K | — | $0 |
| May 21, 2025 | AyurMaya Capital Management Company, LP | Director, 10% Owner | Grant(A) | 4.5M | — | — |
| May 21, 2025 | Machado Patrick | Director | Grant(A) | 7K | — | — |
| May 21, 2025 | Machado Patrick | Director | Grant(A) | 11K | — | — |
| May 21, 2025 | Machado Patrick | Director | Grant(A) | 41K | — | — |
| May 21, 2025 | Machado Patrick | Director | Grant(A) | 14K | — | — |
| May 21, 2025 | Machado Patrick | Director | Grant(A) | 20K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).